Omega Therapeutics, Inc. revenue breakdown overview

Omega Therapeutics, Inc. revenue for the last year amounted to 3.09 M USD, the most of which — 3.09 M USD — came from its highest performing source at the moment, Programmable Epigenomic mRNA Medicines, the year earlier bringing 2.07 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Omega Therapeutics, Inc. 3.09 M USD, and the year before that — 2.07 M USD.